(Date:7/2/2008)...ed on cells manufactured from bone marrow; SV L...SALT LAKE CITY and HAMBURG, Germany, July 2 /PRNew...t the forefront of innovative cell therapies,for t...ed the closing of a,$14.5MM Series A financing. Th...joining the syndicate., "This financing represent...
(Date:7/2/2008)...ma, a leading provider of,knowledge management sol...,industry, announced today that the Aureus Pharma ...er 23rd and 24th., This symposium follows last ye...ttended by many of Aureus, pharmaceutical and biot...The symposium included presentations,from industry...
(Date:7/2/2008)...xpanded Portfolio of Vascular ... July 2 /- Neovasc Inc. (TSXV:,NVC), ...pany developing and,marketing innovative specialty... and the expansion of its product portfolio, as th...r product development companies and the,closing of...
(Date:7/2/2008)...tment R2 levels as a possible p.../ Lorus Therapeutics Inc. (...), a biopharmaceutical company,specializing in the...ts and,technologies for the management of cancer, ...rsity (OSU) clinical team of a paper entitled "Pha...
Breaking Biology Technology:AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Aureus Pharma Announces Date of 2008 Annual User Symposium 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5...ys Wall Street Journal detailed the news of anot... have talked about the consolidation of the Japane...ving late to the consolidation party as both Ameri... for years and continue to consolidate. , , , ,N...uire other major pharmaceutical companies (except ...
...e or chalk outlines of a body, but companies need ...nt remedies, said a lawyer who spoke at the Fusio...Vaccaro, a partner with Michael Best & Friedrich ...compromised by Internet fraudsters or disgruntled ...aw enforcement. , ,"You get to ride on the backs o...
...in has a warning for chief information officers: B...be made by lower-level business executives. The CE...in Oconomowoc, said CIOs will have to work to stay...s on decisions of outsourcing vs. insourcing. , ,"...me," he said. "If you want to change that, then ge...
... chief information officers for their number-one i...ity or bandwidth. , ,Today, the consensus issue is...curities legislation, highlighted by Congress,s pa...s it has come to be called. SOX, which was passed ... brought down the likes of Enron and Adelphia, add...
Other Biology Technology:Japan's pharma mergers will trickle to the Midwest 2Japan's pharma mergers will trickle to the Midwest 3Japan's pharma mergers will trickle to the Midwest 4After a successful attack on your computer systems, then what? 2After a successful attack on your computer systems, then what? 3IT outsourcing remains on the horizon as companies focus on core business 2IT outsourcing remains on the horizon as companies focus on core business 3With Sarbanes-Oxley, compliance takes center stage for CIOs 2With Sarbanes-Oxley, compliance takes center stage for CIOs 3...assava plants produced roots that were more than t...ts. , The findings could help ease hunger in many ... plant (Manihot esculenta) as a primary food sourc... a professor of plant cellular and molecular biolo...ed a gene from the bacterium E. coli to geneticall...
... identified a molecule that plays a key role in es...h side of the adult brain. , QBI neural migration...said her group,s research provided new clues regar...connecting nerve tract that shuttles information b... brain. , Using a mouse model, neuroscientists a...
...mates have long puzzled scientists, and several sc...t true members of the group appeared virtually sim... 55 million years ago. , But new research using ...t migration path from those previously proposed an...e the dispersal. , Researchers from the Univers...
...y recently been discovered and, paradoxically, ind...state, may represent a novel target for the treatm...ding to new research presented at the 6th Internat...CN 2006 is being held at the David L. Lawrence Con...eptide S (NPS), so named by Rainer K. Reinscheid, ...
Other Biology News:Super-sized cassava plants may help fight hunger in Africa 2Ancient global warming drove early primates' dispersal 2Studies suggest new brain protein may help in treating schizophrenia, insomnia and anxiety 2Anti-ADP-Ribosylation Factor 1, clone 3F1 Immunogen: Synthetic peptide corresponding to the C-terminal amino acid sequence of human ARF1. Available Date: 38495
PMA (YPMA-1)
Polyclonal Antibody to CRTR-1
FEN-1 (B-4)
Biology Products: